Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury - PubMed (original) (raw)
. 2007 Jul 4;81(4):288-98.
doi: 10.1016/j.lfs.2007.05.023. Epub 2007 Jun 13.
Affiliations
- PMID: 17612572
- DOI: 10.1016/j.lfs.2007.05.023
Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury
Szu-Fu Chen et al. Life Sci. 2007.
Abstract
Traumatic brain injury (TBI) triggers a complex sequence of inflammatory responses that contribute to secondary injury. Statins have demonstrated neuroprotective effects against brain injury, but the underlying mechanisms remain unclear. This study evaluated the effects of lovastatin on a rat model of controlled cortical impact (CCI) injury. Our two hypotheses were that pre-administration of lovastatin would reduce functional deficits and extent of anatomical brain damage and that lovastatin would attenuate levels of pro-inflammatory cytokines. Rats were injected with lovastatin (4 mg/kg) or vehicle for 5 days and subjected to CCI. Neurological status was evaluated using rotarod and adhesive removal tests. Contusion volume and neuronal degeneration were examined using cresyl violet and FluoroJade B (FJB) histochemistry. Levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) mRNA and protein were assessed by real-time quantitative reverse transcriptase polymerase chain reaction, enzyme-linked immunosorbent assay, and immunohistochemistry. Lovastatin significantly improved performance on both the rotarod and adhesive removal tests before post-injury day 7. Lovastatin also significantly reduced contusion volume (20%) and number of FJB-positive degenerating neurons (35%) at 4 days. These changes were associated with a significant decrease in levels of TNF-alpha and IL-1beta mRNA and protein at the contusion site at 6 h and 4 days, respectively. Our results show that pre-administration of lovastatin improved functional outcomes and reduced extent of brain damage, with a concomitant decrease in tissue levels of TNF-alpha and IL-1beta mRNA and protein. These findings suggest that lovastatin's protective mechanisms may be partly attributed to a dampening of the inflammatory response.
Similar articles
- Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury.
He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. He J, et al. Exp Neurol. 2004 Oct;189(2):404-12. doi: 10.1016/j.expneurol.2004.06.008. Exp Neurol. 2004. PMID: 15380490 - Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway.
Chen G, Zhang S, Shi J, Ai J, Qi M, Hang C. Chen G, et al. Exp Neurol. 2009 Apr;216(2):398-406. doi: 10.1016/j.expneurol.2008.12.019. Epub 2009 Jan 7. Exp Neurol. 2009. PMID: 19166837 - Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
Chen G, Shi JX, Hang CH, Xie W, Liu J, Liu X. Chen G, et al. Neurosci Lett. 2007 Oct 2;425(3):177-82. doi: 10.1016/j.neulet.2007.08.022. Epub 2007 Aug 19. Neurosci Lett. 2007. PMID: 17825990 - Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
Kumar A, Loane DJ. Kumar A, et al. Brain Behav Immun. 2012 Nov;26(8):1191-201. doi: 10.1016/j.bbi.2012.06.008. Epub 2012 Jun 21. Brain Behav Immun. 2012. PMID: 22728326 Review. - Human umbilical cord blood cells or estrogen may be beneficial in treating heatstroke.
Chen SH, Huang KF, Lin MT, Chang FM. Chen SH, et al. Taiwan J Obstet Gynecol. 2007 Mar;46(1):15-25. doi: 10.1016/S1028-4559(08)60101-1. Taiwan J Obstet Gynecol. 2007. PMID: 17389184 Review.
Cited by
- The protective effects of statins in traumatic brain injury.
Pordel S, McCloskey AP, Almahmeed W, Sahebkar A. Pordel S, et al. Pharmacol Rep. 2024 Apr;76(2):235-250. doi: 10.1007/s43440-024-00582-9. Epub 2024 Mar 7. Pharmacol Rep. 2024. PMID: 38448729 Review. - The neuroprotective potential of phytochemicals in traumatic brain injury: mechanistic insights and pharmacological implications.
Hasan GM, Anwar S, Shamsi A, Sohal SS, Hassan MI. Hasan GM, et al. Front Pharmacol. 2024 Jan 4;14:1330098. doi: 10.3389/fphar.2023.1330098. eCollection 2023. Front Pharmacol. 2024. PMID: 38239205 Free PMC article. Review. - HMG-CoA Reductase Inhibitors for Traumatic Brain Injury.
Katlowitz K, Gopinath S, Cruz Navarro J, Robertson C. Katlowitz K, et al. Neurotherapeutics. 2023 Oct;20(6):1538-1545. doi: 10.1007/s13311-023-01399-9. Epub 2023 Jun 23. Neurotherapeutics. 2023. PMID: 37351829 Free PMC article. Review. - A Systematic Review on Traumatic Brain Injury Pathophysiology and Role of Herbal Medicines in its Management.
Arora K, Vats V, Kaushik N, Sindhawani D, Saini V, Arora DM, Kumar Y, Vashisht E, Singh G, Verma PK. Arora K, et al. Curr Neuropharmacol. 2023;21(12):2487-2504. doi: 10.2174/1570159X21666230126151208. Curr Neuropharmacol. 2023. PMID: 36703580 Free PMC article. - Neuro-Inflammation Modulation and Post-Traumatic Brain Injury Lesions: From Bench to Bed-Side.
Jacquens A, Needham EJ, Zanier ER, Degos V, Gressens P, Menon D. Jacquens A, et al. Int J Mol Sci. 2022 Sep 23;23(19):11193. doi: 10.3390/ijms231911193. Int J Mol Sci. 2022. PMID: 36232495 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical